Concepedia

Author

J McKendrick

Box Hill Hospital

Also Known As

J McKendrick, J Mckendrick, J. J. McKendrick, J. McKendrick, J.J McKendrick, J.J. McKendrick, JJ McKendrick

60

Publications

695

Citations

9

H-Index

22

Concepts

All Affiliations

Box Hill HospitalPeter MacCallum Cancer CentreWessex Medical ResearchThe Royal Melbourne HospitalThe Alfred Hospital
JM

About

J McKendrick is an author at Box Hill Hospital specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

510

2

Health Sciences

1

1

68

3

Gastroenterology

1

1

13

4

Immunology

1

1

103

5

Marrow Transplantation

1

1

68

J McKendrick

×

9

Publications

637

Citations

9

H-Index

YearCitations

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial

Werner Scheithauer, J McKendrick, S. Begbie,

Annals of Oncology

2003

272

First-line bevacizumab combined with reduced dose interferon-α2a is active in patients with metastatic renal cell carcinoma

Bohuslav Melichar, P. Koralewski, Alain Ravaud,

Annals of Oncology

2008

103

Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield

Tara Seshadri, Debra A. Gook, Stephen Lade,

British Journal of Cancer

2006

96

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

Andrew Spencer, Noemi Horvath, John Gibson,

Bone Marrow Transplantation

2005

68

Results From VELOUR, a Phase 3 Study of Aflibercept (A) Versus Placebo (pbo) in Combination with FOLFIRI for the Treatment of Patients (pt) with Previously Treated Metastatic Colorectal Cancer (MCRC)

Josep Tabernero, Eric Van Cutsem, Radek Lakomý,

European Journal of Cancer

2011

33

ChlVPP chemotherapy in advanced Hodgkin's disease

J McKendrick, Graham M. Mead, John Sweetenham,

European Journal of Cancer and Clinical Oncology

1989

21

A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC

Michalis Michael, A. Wirth, D. Ball,

British Journal of Cancer

2005

17

Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients: Medical resource utilization (MRU) data from a large phase III trial (X-ACT)

J McKendrick, J Cassidy, S Chakrapee-Sirisuk,

Journal of Clinical Oncology

2004

14

Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment

JW Sweetenham, GM Mead, D H Wright,

British Journal of Cancer

1989

13

Page 1